Literature DB >> 12615754

Diagnosis and management of Graves' disease.

Jody Ginsberg1.   

Abstract

Graves' disease is characterized by hyperthyroidism, diffuse goitre, ophthalmopathy and, rarely, dermopathy. Although diagnostic testing is straightforward once Graves' disease is suspected, physicians need to be aware of heterogeneous and even atypical presentations of the disease, particularly in elderly patients. Because morbidity may be associated with even subtle forms of hyperthyroidism, treatment promoting long-term euthyroidism is necessary. Although all of the available treatments are effective, compliance is best assured by a full discussion of the risks and benefits of each approach. This review focuses on issues of diagnosis and management that will allow the primary care physician to identify patients with Graves' disease and guide them to recovery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615754      PMCID: PMC149254     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  52 in total

Review 1.  Graves' disease is a multi-system autoimmune disorder in which extra ocular muscle damage and connective tissue inflammation are variable features.

Authors:  Jack R Wall
Journal:  Thyroid       Date:  2002-01       Impact factor: 6.568

Review 2.  Clinical practice. Subclinical hyperthyroidism.

Authors:  A D Toft
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

3.  TSH receptor antibody synthesis by thyroid lymphocytes.

Authors:  S M McLachlan; C A Pegg; M C Atherton; S L Middleton; F Clark; B Rees Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1986-02       Impact factor: 3.478

4.  Apathetic thyrotoxicosis: A distinctive clinical and laboratory entity.

Authors:  F B Thomas; E L Mazzaferri; T G Skillman
Journal:  Ann Intern Med       Date:  1970-05       Impact factor: 25.391

5.  Thyroid cancer yield in patients with Graves' disease selected for surgery on the basis of cold scintiscan defects.

Authors:  Derek J Stocker; Sherwin S Foster; Barbara L Solomon; Craig D Shriver; Henry B Burch
Journal:  Thyroid       Date:  2002-04       Impact factor: 6.568

6.  Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease.

Authors:  V Sridama; M McCormick; E L Kaplan; R Fauchet; L J DeGroot
Journal:  N Engl J Med       Date:  1984-08-16       Impact factor: 91.245

Review 7.  Antithyroid drugs.

Authors:  D S Cooper
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

8.  Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.

Authors:  A Allahabadia; J Daykin; M C Sheppard; S C Gough; J A Franklyn
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

9.  Treatment of hyperthyroidism with a small single daily dose of methimazole.

Authors:  A Shiroozu; K Okamura; H Ikenoue; K Sato; T Nakashima; M Yoshinari; M Fujishima; T Yoshizumi
Journal:  J Clin Endocrinol Metab       Date:  1986-07       Impact factor: 5.958

10.  Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose.

Authors:  D S Cooper; D Goldminz; A A Levin; P W Ladenson; G H Daniels; M E Molitch; E C Ridgway
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

View more
  19 in total

1.  Graves' disease in children.

Authors:  Jennifer Webster; Shayne P Taback; Elizabeth A C Sellers; Heather J Dean
Journal:  CMAJ       Date:  2003-07-22       Impact factor: 8.262

2.  Asymmetric ophthalmopathy in a hypothyroid patient.

Authors:  Taryn Taylor; Charles Czarnowski
Journal:  Can Fam Physician       Date:  2007-04       Impact factor: 3.275

3.  Graves' exophthalmos: Volumetric assessment of orbital expansion.

Authors:  Ramon S Grover; James Mainprize; Edsel Ing; Oleh M Antonyshyn
Journal:  Can J Plast Surg       Date:  2003

4.  Potassium Supplementation to Prevent Severe Hypokalemia and Paralysis after High-Dose Methylprednisolone for Ophthalmopathy in Uncontrolled Graves Disease: A Case Report.

Authors:  Alix-Anne Gendron; Antoine Marquis; Carolanne Mongeon; Andreea Statie; Audrey Bouchard; Michael Khazaka
Journal:  Can J Hosp Pharm       Date:  2022-07-04

5.  Effect of near-total thyroidectomy on thyroid orbitopathy due to toxic goiter.

Authors:  Yasser A Elsayed; Atif M Abdul-Latif; Mukhtar F Abu-Alhuda; Hosam A-F Halim
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

6.  Resistant thyrotoxicosis in a patient with graves disease: a case report.

Authors:  Taimur Saleem; Aisha Sheikh; Qamar Masood
Journal:  J Thyroid Res       Date:  2011-08-10

7.  Hyperthyroidism with concurrent FMS-like tyrosine kinase 3-internal tandem duplication-positive acute promyelocytic leukemia: A case report and review of the literature.

Authors:  Yajian Jiang; Keyue Hu; Wanzhuo Xie; Gaofeng Zheng; Jie Sun; Yanlong Zheng; He Huang
Journal:  Oncol Lett       Date:  2013-11-29       Impact factor: 2.967

8.  Epidemiology, management and outcomes of Graves' disease-real life data.

Authors:  Y S Hussain; J C Hookham; A Allahabadia; S P Balasubramanian
Journal:  Endocrine       Date:  2017-05-06       Impact factor: 3.633

9.  Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child.

Authors:  In Su Choi; Han Kyul Kim; Dong Kyun Han; Hee Jo Baek; Hae In Jang; Chan Jong Kim; Hoon Kook
Journal:  Korean J Pediatr       Date:  2015-07-22

10.  The association of carotid cavernous fistula with Graves' ophthalmopathy.

Authors:  Ozlem Celik; Deram Buyuktas; Civan Islak; A Murat Sarici; A Sadi Gundogdu
Journal:  Indian J Ophthalmol       Date:  2013-07       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.